Acknowledgement
This work was supported by funding from the Catholic Medical Center Research Foundation made in the program year of 2020 (to J.K.) and the Korea Institute of Science & Technology Research Program (2E31300).
References
- Weidinger S and Novak N (2016) Atopic dermatitis. Lancet 387, 1109-1122 https://doi.org/10.1016/S0140-6736(15)00149-X
- Silverberg JI (2019) Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 123, 144-151 https://doi.org/10.1016/j.anai.2019.04.020
- Mack MR and Kim BS (2018) The itch-scratch cycle: a neuroimmune perspective. Trends Immunol 39, 980-991 https://doi.org/10.1016/j.it.2018.10.001
- Brunello L (2018) Atopic dermatitis. Nat Rev Dis Primers 4, 2 https://doi.org/10.1038/s41572-018-0004-9
- Boguniewicz M and Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242, 233-246 https://doi.org/10.1111/j.1600-065X.2011.01027.x
- Yamanishi Y, Mogi K, Takahashi K, Miyake K, Yoshikawa S and Karasuyama H (2020) Skin-infiltrating basophils promote atopic dermatitis-like inflammation via IL-4 production in mice. Allergy 75, 2613-2622 https://doi.org/10.1111/all.14362
- Vestergaard C, Wollenberg A and Thyssen JP (2020) European Task Force on Atopic Dermatitis (ETFAD) Position Paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J Eur Acad Dermatol Venereol 34, 426-427 https://doi.org/10.1111/jdv.16171
- Thyssen JP, Vestergaard C, Deleuran M et al (2020) European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis. J Eur Acad Dermatol Venereol 34, e839-e842 https://doi.org/10.1111/jdv.16716
- Wu J and Guttman-Yassky E (2020) Efficacy of biologics in atopic dermatitis. Expert Opin Biol Ther 20, 525-538 https://doi.org/10.1080/14712598.2020.1722998
- Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M and O'Shea JJ (2017) JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov 17, 78
- Eichenfield LF, Ahluwalia J, Waldman A, Borok J, Udkoff J and Boguniewicz M (2017) Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol 139, S49-S57 https://doi.org/10.1016/j.jaci.2017.01.009
- Strehl C, Ehlers L, Gaber T and Buttgereit F (2019) Glucocorticoids-all-rounders tackling the versatile players of the immune system. Front Immunol 10, 1744 https://doi.org/10.3389/fimmu.2019.01744
- Akinlade B, Guttman-Yassky E, de Bruin-Weller M et al (2019) Conjunctivitis in dupilumab clinical trials. Br J Dermatol 181, 459-473 https://doi.org/10.1111/bjd.17869
- Mechesso AF, Lee SJ, Park NH et al (2019) Preventive effects of a novel herbal mixture on atopic dermatitis-like skin lesions in BALB/C mice. BMC Complement Altern Med 19, 25 https://doi.org/10.1186/s12906-018-2426-z
- Yun Y, Kim K, Choi I and Ko SG (2014) Topical herbal application in the management of atopic dermatitis: a review of animal studies. Mediators Inflamm 2014, 752103 https://doi.org/10.1155/2014/752103
- Kim JH, Kim YH and Yoon CY (2010) Vascular plants of the Hongcheon-gun area in Gangwon province - Mt. Gyebang, Mt. Gongjak, Mt. Daeryong, Mt. Maehwa, Mt. Eungbong, and Chimseok peak. Korean J Environ Ecol 24, 32
- Weidinger S, Beck LA, Bieber T, Kabashima K and Irvine AD (2018) Atopic dermatitis. Nat Rev Dis Primers 4, 1
- Bieber T (2022) Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov 21, 21-40 https://doi.org/10.1038/s41573-021-00266-6
- MacGlashan D Jr (2008) IgE receptor and signal transduction in mast cells and basophils. Curr Opin Immunol 20, 717-723 https://doi.org/10.1016/j.coi.2008.08.004
- Bhaskar S and Helen A (2016) Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats. Mol Cell Biochem 423, 53-65 https://doi.org/10.1007/s11010-016-2824-9
- Ko E, Park S, Lee JH et al (2019) Ginsenoside Rh2 ameliorates atopic dermatitis in NC/Nga mice by suppressing NF-kappaB-mediated thymic stromal lymphopoietin expression and T helper type 2 differentiation. Int J Mol Sci 20, 6111 https://doi.org/10.3390/ijms20246111
- Choi YJ, Lee HJ, Lee DH et al (2013) Therapeutic effects and immunomodulation of suanbo mineral water therapy in a murine model of atopic dermatitis. Ann Dermatol 25, 462-470 https://doi.org/10.5021/ad.2013.25.4.462
- Kasraie S and Werfel T (2013) Role of macrophages in the pathogenesis of atopic dermatitis. Mediators Inflamm 2013, 942375
- Bao K and Reinhardt RL (2015) The differential expression of IL-4 and IL-13 and its impact on type-2 immunity. Cytokine 75, 25-37 https://doi.org/10.1016/j.cyto.2015.05.008
- Junttila IS (2018) Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes. Front Immunol 9, 888 https://doi.org/10.3389/fimmu.2018.00888
- Lin SH, Chuang HY, Ho JC, Lee CH and Hsiao CC (2018) Treatment with TNF-alpha inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation. J Dermatol Sci 91, 276-284 https://doi.org/10.1016/j.jdermsci.2018.05.009
- Toma W, Trigo JR, de Paula AC and Brito AR (2004) Preventive activity of pyrrolizidine alkaloids from Seneciobrasiliensis (Asteraceae) on gastric and duodenal induced ulcer on mice and rats. J Ethnopharmacol 95, 345-351 https://doi.org/10.1016/j.jep.2004.08.017